miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5

Breast Cancer: Targets and Therapy · Published 2026-07-01 · DOI 10.2147/bctt.s615715

Free full text

Authors (5)

Linna Kong, Huihui Zhang, Xufang Sui, Xueping Peng, Tiantian Sun

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kong, L., Zhang, H., Sui, X., et al. (2026). miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5. Breast Cancer: Targets and Therapy. https://doi.org/10.2147/bctt.s615715

Related articles

• Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Discrimination of Triple-Negative Breast Cancer: A Robust Clinical Baseline versus Multimodal Magnetic Resonance Imaging Integrated Models with Assessment of Generalizability · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation · Breast Cancer: Targets and Therapy · 2026 · Same journal
• ADPB Sensitivity in Breast Cancer is Correlated with LAT1 Expression: An in vitro Study of a Novel Theranostic Candidate · Breast Cancer: Targets and Therapy · 2026 · Same journal
• AIM2 Lactylation Regulates Radiotherapy Sensitivity in Triple-Negative Breast Cancer · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Combined Treatment with Shuyu Pills and Everolimus Suppresses Triple-Negative Breast Cancer Growth via the PI3K/AKT/mTOR Pathway · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Prognostic Significance of the CRP-Albumin-Lymphocyte Index (CALLY) in Triple Negative Breast Cancer Patients: A Real-World Retrospective Study · Breast Cancer: Targets and Therapy · 2026 · Same journal
• Lipid Metabolism and Breast Cancer Therapy: An Integrative Literature Review · Breast Cancer: Targets and Therapy · 2026 · Same journal